Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial

Transplant Proc. 1995 Feb;27(1):1140-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Female
  • Graft Rejection / epidemiology
  • Humans
  • Immunosuppression / methods
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Prospective Studies
  • Receptors, Interleukin-2 / immunology*
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Receptors, Interleukin-2
  • inolimomab